Joseph Torrisi retweeted
Replying to @t11bmartin
@t11bmartin @elipwilber @JoeTPharmD @AdvaniShreena: The impact of implementation of rapid blood culture identification panels on #antimicrobial optimization: a retrospective cohort study bit.ly/3xDkOa2
Joseph Torrisi retweeted
Replying to @EmoryMedicine
Joseph Torrisi retweeted
💥Critical Care Pharmacist job opening @GradyHealth - only Level 1 Trauma ➕Comprehensive Stroke Center ➕Burn Center in Atlanta, Georgia. Lots of growth in the upcoming years and an exciting opportunity for ICU pharmacists. Come join our team! 🏥 Contact [email protected] for info
Joseph Torrisi retweeted
Happy July!! Our MICU team getting a well deserved break with our favorite pups @emoryimchiefs @EmoryCCC @EmoryDeptofMed
Joseph Torrisi retweeted
🆕 Episode of #Breakpoints! 🫁
Curious about controversies in the management of HAP/VAP? Let’s clear the air!
Check out this infographic from @littlebugdrug and @moore_wjustin and listen along as Drs. @dblake096, @owenralb, and Ryan Rivosecchi join @ErinMcCreary to discuss!
Joseph Torrisi retweeted
🔥🔥Just published 🔥🔥
@iwgdf / @IDSAInfo 2023
Guidelines on the diagnosis and treatment of foot infection in persons with diabetes
Check 🌟table 5🌟 similar to our OM @Wiki_Guidelines recomm #shorterisbetter theme is prevailing! #IDTwitter
iwgdfguidelines.org/infectio…
#IDTwitter
Joseph Torrisi retweeted
In update published today
@US_FDA now warning doctors prescribing @AstraZeneca's Evusheld to inform patients of
"increased risk for developing COVID-19 when exposed to variants of SARS-CoV-2 that are not neutralized"
fda.gov/drugs/drug-safety-an…

ALT A screenshot from the webpage linked in this tweet. This sentence is highlighted: "FDA added important information to the authorized Fact Sheets for Evusheld (tixagevimab co-packaged with cilgavimab) to inform health care providers and individuals receiving Evusheld of the increased risk for developing COVID-19 when exposed to variants of SARS-CoV-2 that are not neutralized by Evusheld"
Joseph Torrisi retweeted
Logging in to see the pt you de-esc’d to cefazolin yesterday is now on meropenem #IDTwitter
Joseph Torrisi retweeted
🆕⚡⚡ematic Review & Meta-Analysis @CIDJournal @DrToddLee 🌟s @BogochIsaac @DrEmilyMcD
Revisiting the Evidence Base for Modern Day Practice of Treatment of Toxoplasmic Encephalitis
TMP-SMX appears to be as effective & safer than pyrimethamine-containing academic.oup.com/cid/advance…
Joseph Torrisi retweeted
We love a stoplight table! Check out this great summary made by @moore_wjustin of PsA resistance 🦠 to beta-lactams from the recent #Breakpoints discussion with @erinmccreary, @MaggieMonogue, and @aoliverp73. Then listen to the episode for all the details: sidp.pinecast.co
Joseph Torrisi retweeted
Beta-lactam antibiotic therapeutic drug monitoring in critically ill patients: a systematic review and meta-analysis et al.
✅ Just Accepted
🔗 https://xitter.gq/t.co/ig1eCQnegv
Joseph Torrisi retweeted
Happy #IDPharmacists Day! So grateful for the Atlanta ID Pharmacists fighting against antimicrobial resistance @JoeTPharmD @mpatel197272 @pharmertrinh @ViridansPharmD @Albrechtazole not pictured (@ASPGuruPharmD @summerasize @AdvaniShreena)
#IDTwitter #RxTwitter @SIDPharm
Joseph Torrisi retweeted
IDSA releases updated AMR Gram Negative Guidance on the treatment of infections caused by ESBL-E, CRE, and DTR-P. aeruginosa: https://xitter.gq/t.co/xesmEZkhEv
#IDSAGuidelines #antimicrobialresistance
Joseph Torrisi retweeted
Disappointed by this statement from the @AmerMedicalAssn. Instead of finding a way to work effectively with #pharmacists, they state this is “risky” and imply that #pharmacists can’t interpret “6 pages of DDI” (which is actually our jobs). #dobetter @ASHPOfficial
Joseph Torrisi retweeted
New RECOVERY result: Baricitinib
8156 patients randomly allocated to receive usual care plus baricitinib versus usual care alone.
28-day mortality lower in patients allocated baricitinib: 513/4148 (12%) vs 546/4008 (14%) (age-adjusted rate ratio 0.87; 95% CI 0.77-0.98; p=0.026)
Joseph Torrisi retweeted
New publication alert‼️ Incidence of BL Neurotoxicity lower than previously thought & weight a novel risk factor for neurotoxicity?! 🧠🤔 check it out ⬇️⬇️ link.springer.com/article/10…
Joseph Torrisi retweeted
The authors aimed to further their understanding of antimicrobial reasoning in pharmacists and compare their reasoning processes to physicians. buff.ly/3FQ79eo @KatherineGberg @EmilyAbdoler @bobrien_15 @BschwartzinSF @ConanMacDougall @accpinfdprn






























